LIPO: Lipella Stock Price

Lipella Pharmaceuticals (LIPO) is actively advancing clinical trials, developing innovative drug delivery methods for the treatment of head and neck cancer, as well as cystitis. This price chart on GURU.Markets reflects 0.85. The business relies on modifying the composition of established medications for urological pathologies. Experts value Lipella Pharmaceuticals for its pursuit of treatment methods for severe urinary tract lesions.

Quote Chart: Lipella Pharmaceuticals (LIPO) for 04/28/2023 - 07/19/2025

Lipella Pharmaceuticals Inc - analytical breakdowns and key metrics (LIPO)

- stock value and consensus price forecast:

Price Chart Lipella Pharmaceuticals|LIPO - Price Target Chart

- market capitalization information:

Market Capitalization Lipella Pharmaceuticals Inc|LIPO - Company Buyout Price

- book capitalization information:

Net Assets per Single Share Lipella Pharmaceuticals|LIPO - Net Asset Value|Market Value to Book Value Ratio lipella.com|LIPO - Company Assets

- debt and liquidity details:

- company profitability and valuation multiples indicators:

LIPO - Net Income|Projected Future Earnings Lipella Pharmaceuticals|LIPO - P/E Multiple|Projected Price to Earnings Lipella Pharmaceuticals, Inc.|LIPO - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lipella Pharmaceuticals Inc|LIPO - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Lipella Pharmaceuticals|LIPO - Earnings per share for the last four quarters|Quarterly EPS earnings growth lipella.com|LIPO - Earnings per share increase in current year|Earnings growth forecast for next year Lipella Pharmaceuticals

- sales and revenue indicators:

LIPO - Company Total Revenue|Company Projected Revenue Lipella Pharmaceuticals|LIPO - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Lipella Pharmaceuticals Inc

Fundamental valuation:Lipella Pharmaceuticals

Signature product of Lipella Pharmaceuticals Inc

Price serves as an integral market indicator, aggregating all fundamental investor expectations into the value of a single share. By analyzing this snapshot of exchange quotes, one can assess how the market capitalizes the successes of Lipella Pharmaceuticals (LIPO) in the development of LP-10 and the potential integration of their bladder cancer therapy into US medical protocols.

Analysis of competing companies